Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a ???Smart??? Probe Answer!, Journal of Medicinal Chemistry, vol.58, issue.11, pp.4521-4528, 2015. ,
DOI : 10.1021/acs.jmedchem.5b00480
Targeting immune checkpoints in lymphoma, Current Opinion in Hematology, vol.22, pp.337-342, 2015. ,
DOI : 10.1097/MOH.0000000000000158
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy, Immunological Reviews, vol.10, issue.1, pp.47-59, 2007. ,
DOI : 10.1016/j.jim.2004.03.013
Toll-like receptor 4???dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, pp.1050-1059, 2007. ,
DOI : 10.4049/jimmunol.173.1.307
URL : https://hal.archives-ouvertes.fr/hal-00316924
Immunogenicity of anthracyclines: moving towards more personalized medicine, Trends in Molecular Medicine, vol.14, issue.4, pp.141-151, 2008. ,
DOI : 10.1016/j.molmed.2008.02.002
Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer, Radiotherapy and Oncology, vol.111, issue.2, pp.311-315, 2014. ,
DOI : 10.1016/j.radonc.2014.01.021
Chemotherapy for operable and advanced colorectal cancer, Cancer Treatment Reviews, vol.35, issue.6, pp.509-516, 2009. ,
DOI : 10.1016/j.ctrv.2009.04.003
Nitric oxide stimulates PC12 cell proliferation via cGMP and inhibits at higher concentrations mainly via energy depletion, Nitric Oxide, vol.14, issue.3, pp.238-246, 2006. ,
DOI : 10.1016/j.niox.2005.10.002
S- Nitrosylation in Cancer Cells : To Prevent or to Cause? In Nitric Oxide and Cancer, Pathogenesis and Therapy, 2015. ,
Combinatorial Strategies for the Induction of Immunogenic Cell Death, Frontiers in Immunology, vol.6, p.187, 2015. ,
DOI : 10.3389/fimmu.2015.00187
URL : https://hal.archives-ouvertes.fr/hal-01215586
Nitric oxide and the immune response, Nature Immunology, vol.14, issue.11, pp.907-916, 2001. ,
DOI : 10.1038/ni1001-907
Activation of Akt by the Mammalian Target of Rapamycin Complex 2 Renders Colon Cancer Cells Sensitive to Apoptosis Induced by Nitric Oxide and Akt Inhibitor, J Carcinog Mutagen, vol.8, p.4, 2013. ,
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer, European Journal of Cancer, vol.51, issue.10, pp.1243-1252, 2015. ,
DOI : 10.1016/j.ejca.2015.04.007
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer, N Engl J Med, vol.366, pp.2455-2465, 2012. ,
The yin and yang of nitric oxide in cancer progression, Carcinogenesis, vol.34, issue.3, pp.503-512, 2013. ,
DOI : 10.1093/carcin/bgt034
Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins, Molecular and Cellular Biology, vol.19, issue.8, pp.5237-5246, 1999. ,
DOI : 10.1128/MCB.19.8.5237
Caspasedependent immunogenicity of doxorubicin-induced tumor cell death, J Exp Med, vol.202, pp.1691-1701, 2005. ,
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47, Science Translational Medicine, vol.3, issue.2, pp.63-94, 2010. ,
DOI : 10.1016/S1535-6108(03)00028-X
A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer, International Journal of Colorectal Disease, vol.50, issue.7, pp.727-736, 2012. ,
DOI : 10.1007/s10350-007-0233-6
An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation, Proceedings of the National Academy of Sciences, vol.579, issue.17, pp.12159-12164, 2005. ,
DOI : 10.1016/j.febslet.2005.05.078
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1189320
Identification of the enzymatic mechanism of nitroglycerin bioactivation, Proceedings of the National Academy of Sciences, vol.129, issue.1-2, pp.8306-8311, 2002. ,
DOI : 10.1016/S0009-2797(00)00211-8
Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation, Journal of Oncology Pharmacy Practice, vol.27, issue.2, pp.11-28, 2014. ,
DOI : 10.1056/NEJMoa0808268
Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism, Nitric Oxide, vol.8, issue.2, pp.119-126, 2003. ,
DOI : 10.1016/S1089-8603(02)00147-7
Optimizing the management of metastatic colorectal cancer, Critical Reviews in Oncology/Hematology, vol.75, issue.1, pp.15-26, 2010. ,
DOI : 10.1016/j.critrevonc.2009.09.008
H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway, Oncotarget, vol.6, issue.9, pp.6877-6886, 2015. ,
DOI : 10.18632/oncotarget.3124
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer, Journal of Clinical Oncology, vol.18, issue.16, pp.2938-2947, 2000. ,
DOI : 10.1200/JCO.2000.18.16.2938
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis, Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis, pp.753-762, 2010. ,
DOI : 10.1016/S1470-2045(10)70130-3
Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer, Medical Oncology, vol.15, issue.4, pp.585-591, 2010. ,
DOI : 10.1007/s12032-009-9253-5
A History of Cancer Chemotherapy, Cancer Research, vol.68, issue.21, pp.8643-8653, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-6611
Aerts, and N.s. group. 2015. A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer, Ann Oncol, vol.26, pp.122286-2293 ,
Coumarin-Phosphine-Based Smart Probes for Tracking Biologically Relevant Metal Complexes: From Theoretical to Biological Investigations Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors, European Journal of Inorganic Chemistry Duraiswamy, Cancer Res, vol.73, pp.3591-3603, 2013. ,
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial, J Transl Med, vol.3, p.10, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00092539
Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts, Nitric Oxide, vol.10, issue.3, pp.119-129, 2004. ,
DOI : 10.1016/j.niox.2004.03.006
Phase I study of oxaliplatin in patients with advanced cancer, Cancer Chemotherapy and Pharmacology, vol.12, issue.4, pp.299-303, 1990. ,
DOI : 10.1007/BF00684890
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015. ,
DOI : 10.1016/S1470-2045(12)70137-7
Tyrosine nitration as mediator of cell death, Cellular and Molecular Life Sciences, vol.31, issue.4, pp.3939-3950, 2014. ,
DOI : 10.1016/S0891-5849(01)00600-1
Chemosensitization of Cancer In vitro and In vivo by Nitric Oxide Signaling, Clinical Cancer Research, vol.13, issue.7, pp.2199-2206, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-1807
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, vol.265, issue.5789, pp.373-376, 1980. ,
DOI : 10.1161/01.RES.34.3.317
Innate and adaptive immune cells in the tumor microenvironment, Nature Immunology, vol.179, issue.10, pp.1014-1022, 2013. ,
DOI : 10.1016/j.ijrobp.2012.12.025
Immunogenic cell death in cancer and infectious disease Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Nat Rev Immunol Science, vol.313, pp.1960-1964, 2006. ,
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1?????dependent adaptive immunity against tumors, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors, pp.1170-1178, 2009. ,
DOI : 10.4049/jimmunol.172.6.3399
URL : https://hal.archives-ouvertes.fr/hal-00419823
Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer, Annals of Surgery, vol.220, issue.3, pp.391-398, 1994. ,
DOI : 10.1097/00000658-199409000-00015
Radiotherapy and Immunogenic Cell Death, Seminars in Radiation Oncology, vol.25, issue.1, pp.11-17, 2015. ,
DOI : 10.1016/j.semradonc.2014.07.005
URL : http://doi.org/10.1016/j.semradonc.2014.07.005
A New Group of Chromatin-Associated Proteins with a High Content of Acidic and Basic Amino Acids, European Journal of Biochemistry, vol.4, issue.1, pp.14-19, 1973. ,
DOI : 10.1042/bj0920055
-Nitrosylation, Journal of Biological Chemistry, vol.267, issue.37, pp.26473-26479, 2013. ,
DOI : 10.1074/mcp.R111.013037
URL : https://hal.archives-ouvertes.fr/inria-00621263
Cancer Metastasis: Building a Framework, Cell, vol.127, issue.4, pp.679-695, 2006. ,
DOI : 10.1016/j.cell.2006.11.001
URL : http://doi.org/10.1016/j.cell.2006.11.001
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer, Clinical Colorectal Cancer, vol.14, issue.1, pp.1-10, 2015. ,
DOI : 10.1016/j.clcc.2014.11.002
Safety and Tumor Responses with Lambrolizumab (Anti???PD-1) in Melanoma, New England Journal of Medicine, vol.369, issue.2, pp.134-144, 2013. ,
DOI : 10.1056/NEJMoa1305133
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126516
The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000. ,
DOI : 10.1016/S0092-8674(00)81683-9
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
DOI : 10.1016/j.cell.2011.02.013
Bacillus Calmette-Gu??rin therapy alters the progression of superficial bladder cancer., Journal of Clinical Oncology, vol.6, issue.9, pp.1450-1455, 1988. ,
DOI : 10.1200/JCO.1988.6.9.1450
Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome Nitric oxide and cancer therapy: the emperor has NO clothes, Clin Colorectal Cancer Hickok J.R. Curr Pharm Des, vol.16, pp.381-391, 2010. ,
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial, The Lancet Oncology, vol.13, issue.6, pp.579-588, 2012. ,
DOI : 10.1016/S1470-2045(12)70116-X
Biological chemistry and clinical potential of S-nitrosothiols, Free Radical Biology and Medicine, vol.28, issue.10, pp.1478-1486, 2000. ,
DOI : 10.1016/S0891-5849(00)00248-3
The long road to colorectal cancer therapy: Searching for the right signals, Drug Resistance Updates, vol.13, issue.1-2, pp.44-56, 2010. ,
DOI : 10.1016/j.drup.2009.01.002
In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: Involvement of AIF, Nitric Oxide, vol.20, issue.3, pp.182-194, 2009. ,
DOI : 10.1016/j.niox.2008.11.006
The Extracellular Matrix: Not Just Pretty Fibrils, Science, vol.284, issue.25, pp.1216-1219, 2009. ,
DOI : 10.1074/jbc.M809348200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536535
Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives, Visceral Medicine, vol.32, issue.3, pp.172-177, 2016. ,
DOI : 10.1159/000446486
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide., Proceedings of the National Academy of Sciences, vol.84, issue.24, pp.9265-9269, 1987. ,
DOI : 10.1073/pnas.84.24.9265
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC299734/pdf
Phase I dose escalation trial of??nitroglycerin in addition to??5-fluorouracil and radiation therapy for neoadjuvant treatment of operable rectal cancer, Surgery, vol.158, issue.2, pp.460-465, 2015. ,
DOI : 10.1016/j.surg.2015.04.007
Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors, BMC Cancer, vol.563, issue.1, p.172, 2013. ,
DOI : 10.1016/j.ejphar.2007.02.018
URL : https://hal.archives-ouvertes.fr/inserm-00813522
Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome, J Gastrointest Oncol, vol.7, pp.603-608, 2016. ,
Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.82, issue.19 suppl, pp.69-90, 2011. ,
DOI : 10.1097/00002030-199912240-00012
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status, European Journal of Cancer, vol.45, issue.3, pp.365-373, 2009. ,
DOI : 10.1016/j.ejca.2008.07.016
Biomarkers for personalized oncology: recent advances and future challenges, Metabolism, vol.64, issue.3, pp.16-21, 2015. ,
DOI : 10.1016/j.metabol.2014.10.027
Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis, Biological Chemistry, vol.313, issue.4, pp.365-372, 2006. ,
DOI : 10.1254/jphs.CRJ05004X
Consensus guidelines for the detection of immunogenic cell death, Oncoimmunology, vol.3, p.955691, 2014. ,
-Nitrosation Regulates the Activation of Endogenous Procaspase-9 in HT-29 Human Colon Carcinoma Cells, Journal of Biological Chemistry, vol.3, issue.11, pp.9758-9764, 2004. ,
DOI : 10.1038/35055152
URL : https://hal.archives-ouvertes.fr/hal-00900969
Bioactivation of organic nitrates and the mechanism of nitrate tolerance, Cardiol J, vol.16, pp.11-19, 2009. ,
Transcriptional Regulation of the Human iNOS Gene in Vascular-Smooth-Muscle Cells and Macrophages: Evidence for Tissue Specificity, Biochemical and Biophysical Research Communications, vol.220, issue.3, pp.600-605, 1996. ,
DOI : 10.1006/bbrc.1996.0449
Immunogenic Cell Death in Cancer Therapy, Annual Review of Immunology, vol.31, issue.1, pp.51-72, 2013. ,
DOI : 10.1146/annurev-immunol-032712-100008
Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity, Antioxidants & Redox Signaling, vol.20, issue.7, pp.1098-1116, 2014. ,
DOI : 10.1089/ars.2012.5133
Food intake and colorectal, pp.262-70, 2015. ,
Post-translational modifications induced by nitric oxide (NO): Implication in cancer cells apoptosis, Nitric Oxide, vol.19, issue.2, pp.77-83, 2008. ,
DOI : 10.1016/j.niox.2008.04.014
S-Nitrosylation of the Death Receptor Fas Promotes Fas Ligand???Mediated Apoptosis in Cancer Cells, Gastroenterology, vol.140, issue.7, 2001. ,
DOI : 10.1053/j.gastro.2011.02.053
URL : https://hal.archives-ouvertes.fr/hal-00680824
Chimioradioth??rapie pr??op??ratoire du cancer du rectum??: exp??rience d???un centre, Cancer/Radioth??rapie, vol.19, issue.2, pp.98-105, 2015. ,
DOI : 10.1016/j.canrad.2014.11.011
??-Integrin expression and function modulates presentation of cell surface calreticulin, Cell Death and Disease, vol.9, issue.6, p.2268 ,
DOI : 10.1083/jcb.134.1.227
5-Fluorouracil: mechanisms of action and clinical strategies, Nature Reviews Cancer, vol.3, issue.5, pp.330-338, 2003. ,
DOI : 10.1038/nrc1074
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells, Immunity, vol.38, pp.729-741, 2013. ,
Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy, J Exp Med, vol.208, pp.491-503, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00576679
Fibroblasts as architects of cancer pathogenesis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1832, issue.7, pp.1070-1078, 2013. ,
DOI : 10.1016/j.bbadis.2012.10.013
URL : http://doi.org/10.1016/j.bbadis.2012.10.013
Inhibition of NF-??B by S-Nitrosylation, Biochemistry, vol.40, issue.6, pp.1688-1693, 2001. ,
DOI : 10.1021/bi002239y
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress, Oncogene, vol.335, issue.10, pp.1147-1158, 2011. ,
DOI : 10.1016/j.cell.2010.02.015
Molecular mechanisms of ATP secretion during immunogenic cell death, Cell Death and Differentiation, vol.12, issue.1, pp.79-91, 2014. ,
DOI : 10.1007/s10495-007-0720-1
Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells, Gastroenterology, vol.123, issue.1, pp.235-246, 2002. ,
DOI : 10.1053/gast.2002.34310
Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities, Medicinal Research Reviews, vol.62, issue.481, pp.317-352, 2007. ,
DOI : 10.1016/S0002-9440(10)63835-7
The L-arginine-nitric oxide pathway, N Engl J Med, vol.329, pp.2002-2012, 1993. ,
Regulation of the unfolded protein response via S-nitrosylation of sensors of endoplasmic reticulum stress, Scientific Reports, vol.1292, issue.9961, p.14812, 2015. ,
DOI : 10.1007/978-1-4939-2522-3_14
Calreticulin exposure dictates the immunogenicity of cancer cell death, Nature Medicine, vol.279, issue.1, pp.54-61, 2007. ,
DOI : 10.1038/nm1523
URL : https://hal.archives-ouvertes.fr/inserm-00451702
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death, Cell Death and Differentiation, vol.21, issue.9, pp.1499-1509, 2008. ,
DOI : 10.1007/s00109-007-0214-1
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death, EMBO J, vol.28, pp.578-590, 2009. ,
The blockade of immune checkpoints in cancer immunotherapy, Nature Reviews Cancer, vol.12, issue.4, pp.252-264, 2012. ,
DOI : 10.1038/nrc3237
S-nitrosylation in TNF superfamily signaling pathway: Implication in cancer, Redox Biology, vol.6, pp.507-515, 2015. ,
DOI : 10.1016/j.redox.2015.08.019
Nitric Oxide-Induced Down-Regulation of ??-Catenin in Colon Cancer Cells by a Proteasome-Independent Specific Pathway, Gastroenterology, vol.131, issue.4, pp.1142-1152, 2006. ,
DOI : 10.1053/j.gastro.2006.07.017
Nitric oxide represses inhibitory ??B kinase through S-nitrosylation, Proceedings of the National Academy of Sciences, vol.6, issue.2, pp.8945-8950, 2004. ,
DOI : 10.1074/jbc.M001644200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC428452
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer, New England Journal of Medicine, vol.349, issue.3, pp.247-257, 2003. ,
DOI : 10.1056/NEJMoa022289
Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies? Future Oncol Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils, Oncotarget, vol.5, pp.11442-11451, 2014. ,
Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion, British Journal of Cancer, vol.436, issue.8, pp.1310-1315, 2002. ,
DOI : 10.1038/bjc.1995.274
Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer, Urology, vol.74, issue.4, pp.878-883, 2009. ,
DOI : 10.1016/j.urology.2009.03.004
Nobel Prize Awarded to Scientists for Nitric Oxide Discoveries, Circulation, vol.98, issue.22, pp.2365-2366, 1998. ,
DOI : 10.1161/01.CIR.98.22.2365
[Oxaliplatin: the first DACH platinum in clinical practice], Bull Cancer, vol.84, pp.665-673, 1997. ,
Immunogenic cancer cell death: a key-lock paradigm, Current Opinion in Immunology, vol.20, issue.5, pp.504-511, 2008. ,
DOI : 10.1016/j.coi.2008.05.007
Immunogenic death of colon cancer cells treated with oxaliplatin, Oncogene, vol.177, issue.4, pp.482-491, 2010. ,
DOI : 10.1172/JCI35180
Nitrates and no release: contemporary aspects in biological and medicinal chemistry, Free Radical Biology and Medicine, vol.37, issue.8, pp.1122-1143, 2004. ,
DOI : 10.1016/j.freeradbiomed.2004.06.013
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis, J Clin Oncol, vol.22, pp.3766-3775, 2004. ,
HMG1 and 2, and related ???architectural??? DNA-binding proteins, Trends in Biochemical Sciences, vol.26, issue.3, pp.167-174, 2001. ,
DOI : 10.1016/S0968-0004(01)01801-1
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, N Engl J Med, vol.366, pp.2443-2454, 2012. ,
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration, Nature, vol.304, issue.7092, pp.513-517, 2006. ,
DOI : 10.1038/nature04782
Validation study of the UICC TNM classification of malignant tumors, seventh edition, in breast cancer, Breast Cancer, vol.13, issue.6, pp.748-753, 2014. ,
DOI : 10.1158/1078-0432.CCR-06-2512
Trial Watch: Chemotherapy with immunogenic cell death inducers Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial, Lancet Oncol, vol.12, pp.575-582, 2011. ,
The dual role of iNOS in cancer, Redox Biology, vol.6, pp.334-343, 2015. ,
DOI : 10.1016/j.redox.2015.08.009
Natural Innate and Adaptive Immunity to Cancer, Annual Review of Immunology, vol.29, issue.1, pp.235-271, 2011. ,
DOI : 10.1146/annurev-immunol-031210-101324
Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?, Cancer Research, vol.70, issue.4, pp.1281-1285, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-3276
Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors, Arch Pathol Lab Med, vol.132, pp.1600-1607, 2008. ,
Complete Mesocolic Excision With Central Vascular Ligation Produces an Oncologically Superior Specimen Compared With Standard Surgery for Carcinoma of the Colon, Journal of Clinical Oncology, vol.28, issue.2, pp.272-278, 2010. ,
DOI : 10.1200/JCO.2009.24.1448
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists, Cell Death and Differentiation, vol.261, issue.1, pp.69-78, 2014. ,
DOI : 10.1016/0304-4165(72)90340-6
Randomized Phase II Trial Comparing Nitroglycerin Plus Vinorelbine and Cisplatin With Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.24, issue.4, pp.688-694, 2006. ,
DOI : 10.1200/JCO.2005.04.0436
Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion, The Journal of Immunology, vol.177, issue.11, pp.7889-7897, 2006. ,
DOI : 10.4049/jimmunol.177.11.7889
Immunological aspects of cancer chemotherapy, Nature Reviews Immunology, vol.313, issue.1, pp.59-73, 2008. ,
DOI : 10.4049/jimmunol.172.4.2039
Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart, Probe Answer! J Med Chem, vol.58, pp.4521-4528, 2015. ,